Ambrx Initiates Phase I/II Clinical Trial Of Novel Human Growth Hormone Product Candidate
Tue, 13 Feb 2007 08:00 AM EST
... Ambrx, Inc., announced today that it has initiated a Phase I/II clinical trial of ARX201, a novel, next-generation human growth hormone product candidate. [click link for full article] ...
Related Topics
- Clinical Trials
- Growth Hormones
- Growth Hormone
- Hormones
- Hormone Therapy
- Growth Hormone Deficiency
- Clinical Growth Charts
- Growth Charts
- Human Growth Hormone and Creutzfeldt-Jakob Disease
- Human Growth Hormone
- Factor IX
- Hormone Replacement Therapy
- Growth Disorders
- Psychopharmacology
- Aldosterone
- Somatropin
- Growth hormone excess
- Excess growth hormone
- Household Poisons
- Human Papilloma Virus

Not Signed In -


